Nadofaragene Firadenovec Demonstrates Durable 5-Year Activity in NMIBC
UGN-102 With/Without TURBT Produces Similar DOR and DFS in Newly Diagnosed and Recurrent NMIBC
Dr Wang on the Role of Active Surveillance in Patients With Renal Masses
Dr Meeks on Harnessing Innovation in Bladder Cancer